“The company [Seagate] has a healthy balance sheet with a current ratio of 1.96, earnings yield of 10 percent and the company is set to grow.” Yahoo Finance Performance Comparison: Top 2017 Cheap Stocks 2017 Performance Key Catalyst Clinical trial success Sangamo (SGMO) Big Pharma deal Esperion (ESPR) Cholesterol drug trials Everi Holdings (EVRI) Consumer spending surge Mazda Motor (MZDAY) Steady Growth High "Value" score/low PE
AI responses may include mistakes. For financial advice, consult a professional. Learn more The 10 Best Stocks of 2017 - Yahoo Finance best cheap stocks to buy 2017
This was the standout winner of 2017, returning roughly 516% . The primary driver was positive mid-stage trial results for its treatment for non-alcoholic steatohepatitis (NASH). “The company [Seagate] has a healthy balance sheet